The current institutional shareholding score of Crinetics Pharmaceuticals Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 109.92%, representing a quarter-over-quarter decrease of 10.29%. The largest institutional shareholder is ETHSX, holding a total of 89.70K shares, representing 0.09% of shares outstanding, with 1.00% increase in holdings.